This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07550/identifier/chemspider/
n5http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07550/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07550/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07550/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07550/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07550
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n5:DB07550 n13:DB07550
dcterms:title
2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE
adms:identifier
n8:DB07550 n9:CDD n10:571162 n11:656913 n12:99444021
n3:IUPAC-Name
n6:271B4F64-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B4F6A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B4F69-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B4F66-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B4F67-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B4F68-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B4F62-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B4F63-363D-11E5-9242-09173F13E4C5 n6:271B4F60-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B4F61-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B4F70-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B4F71-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B4F6B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B4F6C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B4F6E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B4F6D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B4F6F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B4F76-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B4F78-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B4F79-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B4F75-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B4F74-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B4F77-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B4F65-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B4F72-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B4F73-363D-11E5-9242-09173F13E4C5